Published in Eur Urol on December 01, 2006
Radical cystectomy--often too late? Yes, but ... Eur Urol (2006) 0.75
2007 guideline for the management of ureteral calculi. J Urol (2007) 4.44
2007 Guideline for the management of ureteral calculi. Eur Urol (2007) 3.98
Laparoscopic versus open adrenalectomy for adrenocortical carcinoma: surgical and oncologic outcome in 152 patients. Eur Urol (2010) 2.49
Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder. Eur Urol (2007) 2.09
Percutaneous nephrolithotomy with ultrasonography-guided renal access: experience from over 300 cases. BJU Int (2005) 1.91
980-nm Diode laser: a novel laser technology for vaporization of the prostate. Eur Urol (2007) 1.79
EAU guidelines on vesicoureteral reflux in children. Eur Urol (2012) 1.76
Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence. Int J Cancer (2010) 1.76
Tumor growth in urinary diversion: a multicenter analysis. Eur Urol (2011) 1.74
The efferent segment in continent cutaneous urinary diversion: a comprehensive review of the literature. BJU Int (2011) 1.59
Flexible ureterorenoscopy for the treatment of lower pole calyx stones: influence of different lithotripsy probes and stone extraction tools on scope deflection and irrigation flow. Eur Urol (2002) 1.50
5-year-follow-up of patients with clinically insignificant residual fragments after extracorporeal shockwave lithotripsy. Eur Urol (2005) 1.50
Last resort in devastated bladder outlet: bladder neck closure and continent vesicostomy--long-term results and comparison of different techniques. Urology (2010) 1.49
Prospective randomized trial comparing flutamide as adjuvant treatment versus observation after radical prostatectomy for locally advanced, lymph node-negative prostate cancer. Eur Urol (2004) 1.47
Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma. Eur Urol (2012) 1.46
Physiologic bladder evacuation with selective sacral root stimulation: sinusoidal signal and organ-specific frequency. Neurourol Urodyn (2002) 1.41
Systematic evaluation of a recently introduced 2-microm continuous-wave thulium laser for vaporesection of the prostate. J Endourol (2008) 1.40
High intensity focused ultrasound as noninvasive therapy for multilocal renal cell carcinoma: case study and review of the literature. J Urol (2002) 1.33
120 W lithium triborate laser for photoselective vaporization of the prostate: comparison with 80 W potassium-titanyl-phosphate laser in an ex-vivo model. J Endourol (2010) 1.29
Metastasis is promoted by a bioenergetic switch: new targets for progressive renal cell cancer. Int J Cancer (2008) 1.27
Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines. Anticancer Res (2005) 1.22
Association of the P-glycoprotein transporter MDR1(C3435T) polymorphism with the susceptibility to renal epithelial tumors. J Am Soc Nephrol (2002) 1.21
Does open stone surgery still play a role in the treatment of urolithiasis? Data of a primary urolithiasis center. J Endourol (2009) 1.18
Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer. PLoS One (2013) 1.17
Low-power holmium:YAG laser urethrotomy for treatment of urethral strictures: functional outcome and quality of life. J Endourol (2006) 1.15
Long-term followup of buccal mucosa onlay graft for hypospadias repair: analysis of complications. J Urol (2004) 1.14
Diverticular carcinoma of the urinary bladder: diagnosis and treatment problems. A case report. Med Princ Pract (2005) 1.13
Donor-site morbidity in buccal mucosa urethroplasty: lower lip or inner cheek? BJU Int (2005) 1.08
Validation of computer-based training in ureterorenoscopy. BJU Int (2005) 1.08
Continent cutaneous urinary diversion: long-term follow-up of more than 800 patients with ileocecal reservoirs. World J Urol (2006) 1.07
MicroRNA 15a, inversely correlated to PKCα, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samples. Am J Pathol (2012) 1.05
Alteration of the LRP1B gene region is associated with high grade of urothelial cancer. Lab Invest (2002) 1.05
The Vista system: a new bipolar resection device for endourological procedures: comparison with conventional resectoscope. Eur Urol (2004) 1.04
A system for long-term urodynamic studies without catheters. Eur Urol (2013) 1.03
Prospective evaluation of acute endocrine pancreatic injury as collateral damage of shock-wave lithotripsy for upper urinary tract stones. BJU Int (2007) 1.03
A biological model to teach percutaneous nephrolithotomy technique with ultrasound- and fluoroscopy-guided access. J Endourol (2007) 1.02
Survival in patients with high-risk prostate cancer is predicted by miR-221, which regulates proliferation, apoptosis, and invasion of prostate cancer cells by inhibiting IRF2 and SOCS3. Cancer Res (2014) 1.02
Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up. Pediatr Nephrol (2004) 1.02
Testis-sparing surgery versus radical orchiectomy in patients with Leydig cell tumors. Urology (2009) 1.02
Two contemporary series of percutaneous tract dilation for percutaneous nephrolithotomy. J Endourol (2009) 1.02
Ventral onlay urethroplasty using buccal mucosa for complex stricture repair. Urology (2003) 1.01
Prediction of pathological and oncological outcomes based on extended prostate biopsy results in patients with prostate cancer receiving radical prostatectomy: a single institution study. Diagn Pathol (2012) 1.00
Solitary schwannoma of the glans penis. Urology (2007) 0.99
Extracorporeal application of high-intensity focused ultrasound for prostatic tissue ablation. BJU Int (2005) 0.99
The past, present and future of minimally invasive therapy in urology: a review and speculative outlook. Minim Invasive Ther Allied Technol (2013) 0.97
Prostate cancer therapy: standard management, new options and experimental approaches. Anticancer Res (2005) 0.96
Cycling and penile oxygen pressure: the type of saddle matters. Eur Urol (2002) 0.95
68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT. Clin Nucl Med (2016) 0.94
Distinct effects of the recurrent Mlh1G67R mutation on MMR functions, cancer, and meiosis. Proc Natl Acad Sci U S A (2008) 0.94
Risk of collateral damage to endourologic tools by holmium:YAG laser energy. J Endourol (2006) 0.93
Improvement in mortality and morbidity in transurethral resection of the prostate over 17 years in a single center. J Endourol (2007) 0.92
Current status of vesicoureteral reflux diagnosis. World J Urol (2004) 0.91
Surgical treatment of renal cell carcinoma with intravascular extension. Interact Cardiovasc Thorac Surg (2004) 0.90
Long-term outcome of ventral buccal mucosa onlay graft urethroplasty for urethral stricture repair. Urology (2004) 0.90
Percutaneous nephrolithotomy and chronic kidney disease: results from the CROES PCNL Global Study. J Urol (2012) 0.89
Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma. BMC Cancer (2014) 0.89
Chronic perforation of the urinary bladder by self-inserted foreign body. Int Urogynecol J Pelvic Floor Dysfunct (2006) 0.89
Diagnosis of vesicoureteric reflux with low-dose contrast-enhanced harmonic ultrasound imaging. Pediatr Radiol (2004) 0.89
Spiradenocylindroma of the kidney: clinical and genetic findings suggesting a role of somatic mutation of the CYLD1 gene in the oncogenesis of an unusual renal neoplasm. Am J Surg Pathol (2002) 0.88
The Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study: tract dilation comparisons in 5537 patients. J Endourol (2011) 0.88
Extracorporeally induced ablation of renal tissue by high-intensity focused ultrasound. BJU Int (2006) 0.88
En bloc transurethral resection of bladder tumors: use and limits. Urology (2003) 0.87
Iatrogenic recto-urethral fistula: perineal repair and buccal mucosa interposition. BJU Int (2008) 0.87
The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer. BJU Int (2006) 0.87
The modern management of upper urinary tract urothelial cancer: tumour diagnosis, grading and staging. BJU Int (2007) 0.87
Urothelial carcinoma of the renal pelvis with choriocarcinomatous features: genetic evidence of clonal evolution. Hum Pathol (2002) 0.87
Technical characterization of a new bipolar and multipolar radiofrequency device for minimally invasive treatment of renal tumours. BJU Int (2006) 0.87
Clinical staging error in prostate cancer: localization and relevance of undetected tumour areas. BJU Int (2009) 0.87
Expression of pro-angiogenic growth factors VEGF, EGF and bFGF and their topographical relation to neovascularisation in prostate cancer. Urol Res (2004) 0.86
MiR-205 is progressively down-regulated in lymph node metastasis but fails as a prognostic biomarker in high-risk prostate cancer. Int J Mol Sci (2013) 0.86
Intravenous contrast media in uroradiology: evaluation of safety and tolerability in almost 50,000 patients. Med Princ Pract (2006) 0.86
Conventional high pressure versus newly developed continuous-flow ureterorenoscope: urodynamic pressure evaluation of the renal pelvis and flow capacity. J Endourol (2008) 0.85
Improved spontaneous erectile function in men with mild-to-moderate arteriogenic erectile dysfunction treated with a nightly dose of sildenafil for one year: a randomized trial. Asian J Androl (2007) 0.85
Impact of mycophenolate mofetil on wound complications and lymphoceles after kidney transplantation. Kidney Blood Press Res (2010) 0.85
Impact of holmium:YAG and neodymium:YAG lasers on the efficacy of DNA delivery in transitional cell carcinoma. Lasers Med Sci (2004) 0.85
Risk of detrusor denervation in antireflux surgery demonstrated in a neurophysiological animal model. J Urol (2003) 0.84
Tumor thrombus of inferior vena cava in patients with renal cell carcinoma - clinical and oncological outcome of 50 patients after surgery. BMC Res Notes (2012) 0.84
New bipolar resection device for transurethral resection of the prostate: first ex-vivo and in-vivo evaluation. J Endourol (2005) 0.84
Paclitaxel encapsulated in cationic liposomes: a new option for neovascular targeting for the treatment of prostate cancer. Oncol Rep (2009) 0.84
The influence of oxalate on renal epithelial and interstitial cells. Urol Res (2004) 0.84
Ureteroscopy for stone treatment using new 270 degrees semiflexible endoscope: in vitro, ex vivo, and clinical application. J Endourol (2007) 0.83
IGF-II serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical staging. Eur Urol (2005) 0.83
Hemostatic properties of four devices for partial nephrectomy: a comparative ex vivo study. J Endourol (2008) 0.83
Expression of different vascular endothelial markers in prostate cancer and BPH tissue: an immunohistochemical and clinical evaluation. Anticancer Res (2004) 0.82
Intrarenal reflux: diagnosis with contrast-enhanced harmonic US. Pediatr Radiol (2003) 0.82
Nitric oxide pathways in human bladder carcinoma. The distribution of nitric oxide synthases, soluble guanylyl cyclase, cyclic guanosine monophosphate, and nitrotyrosine. Cancer (2002) 0.82
Is gender becoming relevant in uro-oncological research? A bibliographical analysis. World J Urol (2013) 0.81
Lymphovascular invasion and pathologic tumor stage are significant outcome predictors for patients with upper tract urothelial carcinoma. Urology (2008) 0.81
The dorsal lamina of the rectus sheath: a suitable grafting material for the penile tunica albuginea in Peyronie's disease? BJU Int (2006) 0.81
Hans Christian Jacobaeus: Inventor of human laparoscopy and thoracoscopy. J Endourol (2006) 0.81
Cytotoxicity of cisplatin in bladder cancer is significantly enhanced by application of bcl-2 antisense oligonucleotides. Urol Oncol (2004) 0.81
Future options for combination therapy in the management of erectile dysfunction in older men. Drugs Aging (2004) 0.81
Serum carcino-embryonic antigen (CEA) and its possible use as tumor marker for secondary tumors in urinary intestinal reservoirs. Urol Oncol (2011) 0.81
Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis. BJU Int (2008) 0.81
Efficacy and safety of a combination of Sabal and Urtica extract in lower urinary tract symptoms--long-term follow-up of a placebo-controlled, double-blind, multicenter trial. Int Urol Nephrol (2007) 0.81
Metformin-Derived Growth Inhibition in Renal Cell Carcinoma Depends on miR-21-Mediated PTEN Expression. Urol Int (2015) 0.81